Identification of paramyosin T cell epitopes associated with human resistance to Schistosoma mansoni reinfection

24Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

Paramyosin, a Schistosoma mansoni myoprotein associated with human resistance to infection and reinfection, is a candidate antigen to compose a subunit vaccine against schistosomiasis. In this study, 11 paramyosin peptides selected by TEPITOPE algorithm as promiscuous epitopes were produced synthetically and tested in proliferation and in vitro human leucocyte antigen (HLA)-DR binding assays. A differential proliferative response was observed in individuals resistant to reinfection compared to individuals susceptible to reinfection in response to Para (210-226) peptide stimulation. In addition, this peptide was able to bind to all HLA-DR molecules tested in HLA-DR binding assays, confirming its promiscuity. Para (6-22) and Para (355-371) were also shown to be promiscuous peptides, because they were able to bind to the six and eight most prevalent HLA-DR alleles used in HLA-DR binding assays, respectively, and were also recognized by T cells of the individuals studied. These results suggest that these paramyosin peptides are promising antigens to compose an anti-schistosomiasis vaccine. © 2005 British Society for Immunology.

Cite

CITATION STYLE

APA

Fonseca, C. T., Cunha-Neto, E., Goldberg, A. C., Kalil, J., De Jesus, A. R., Carvalho, E. M., … Oliveira, S. C. (2005). Identification of paramyosin T cell epitopes associated with human resistance to Schistosoma mansoni reinfection. Clinical and Experimental Immunology, 142(3), 539–547. https://doi.org/10.1111/j.1365-2249.2005.02941.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free